Skip to content

RIGEL PHARMACEUTICALS, INC.: filings

Every RIGEL PHARMACEUTICALS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 61 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-04fiscal Q2 2026411180001034842-26-000052
10-Q2026-05-05fiscal Q1 202643890001034842-26-000032
10-K2026-03-03fiscal FY 2025521350001034842-26-000015
10-Q2025-11-04fiscal Q3 2025451300001104659-25-106268
10-Q2025-08-05fiscal Q2 2025451260001558370-25-010281
10-Q2025-05-06fiscal Q1 202545930001558370-25-006493
10-K2025-03-04fiscal FY 2024491230001558370-25-002169
10-Q2024-11-07fiscal Q3 2024431230001558370-24-014862
10-Q2024-08-06fiscal Q2 2024431190001558370-24-011079
10-Q2024-05-07fiscal Q1 202443890001558370-24-007041
10-K2024-03-05fiscal FY 2023491230001558370-24-002475
10-Q2023-11-07fiscal Q3 2023421180001558370-23-017987
10-Q2023-08-01fiscal Q2 2023421140001558370-23-012722
10-Q2023-05-02fiscal Q1 202342860001558370-23-007653
10-K2023-03-07fiscal FY 2022491220001558370-23-003035
10-Q2022-11-03fiscal Q3 2022431250001558370-22-016266
10-Q2022-08-02fiscal Q2 2022431210001558370-22-011638
10-Q2022-05-03fiscal Q1 202244910001558370-22-006809
10-K2022-03-01fiscal FY 2021471200001558370-22-002551
10-Q2021-11-02fiscal Q3 2021431250001558370-21-014076
10-Q2021-08-03fiscal Q2 2021421170001558370-21-009976
10-Q2021-05-05fiscal Q1 202142870001558370-21-005903
10-K2021-03-02fiscal FY 2020441380001558370-21-002254
10-Q2020-11-05fiscal Q3 202036930001558370-20-012838
10-Q2020-08-04fiscal Q2 202038950001558370-20-009154
10-Q2020-05-05fiscal Q1 202040790001558370-20-005179
10-K2020-02-27fiscal FY 2019431280001558370-20-001624
10-Q2019-11-05fiscal Q3 201935880001558370-19-009974
10-Q2019-08-06fiscal Q2 201933810001558370-19-007232
10-Q2019-05-07fiscal Q1 201932620001558370-19-004244
10-K2019-02-28fiscal FY 2018381140001558370-19-001310
10-Q2018-11-06fiscal Q3 201830650001558370-18-008624
10-Q2018-08-08fiscal Q2 201830660001558370-18-006758
10-Q2018-05-01fiscal Q1 201825510001558370-18-003644
10-K2018-03-06fiscal FY 201731860001558370-18-001555
10-Q2017-11-07fiscal Q3 201726610001558370-17-008378
10-Q2017-08-01fiscal Q2 201726600001558370-17-005590
10-Q2017-05-02fiscal Q1 201722430001558370-17-003254
10-K2017-03-07fiscal FY 201627740001558370-17-001428
10-Q2016-11-01fiscal Q3 201623540001558370-16-008977
10-Q2016-08-02fiscal Q2 201623550001558370-16-007123
10-Q2016-05-03fiscal Q1 201622460001558370-16-005199
10-K2016-03-08fiscal FY 201527720001558370-16-003898
10-Q2015-11-03fiscal Q3 201523560001558370-15-002179
10-Q2015-08-04fiscal Q2 201523560001104659-15-055877
10-Q2015-05-07fiscal Q1 201523480001104659-15-035590
10-K2015-03-03fiscal FY 201429790001047469-15-001563
10-Q2014-11-04fiscal Q3 201423540001104659-14-076408
10-Q2014-08-05fiscal Q2 201423540001104659-14-056803
10-Q2014-05-07fiscal Q1 201423450001104659-14-035662
10-K2014-03-04fiscal FY 201330790001047469-14-001756
10-Q2013-11-05fiscal Q3 201321520001104659-13-080831
10-Q2013-08-06fiscal Q2 201321520001104659-13-060306
10-Q2013-05-07fiscal Q1 201321430001104659-13-038074
10-K2013-03-05fiscal FY 201229830001047469-13-002185
10-Q2012-11-06fiscal Q3 201227720001104659-12-074445
10-Q2012-08-07fiscal Q2 201227720001104659-12-054905
10-Q2012-05-01fiscal Q1 201225520001104659-12-030962
10-K2012-03-06fiscal FY 201127720001047469-12-002146
10-Q2011-11-01fiscal Q3 201126700001104659-11-059341
10-Q2011-08-02fiscal Q2 201130800001104659-11-042450

Inspect the source

Entity
RIGEL PHARMACEUTICALS, INC. / CIK 0001034842
Captured
2026-09-20T05:14:59.255Z
SEC response SHA-256
9f0177d88ba5586af93641453dcdab47e911a8e5133c48ff075ae0e979641d1a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001034842.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))